.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, however the biotech still st...
.Neurocrine Biosciences' schizophrenia course pivot has actually stopped working. The biotech was ac...
.Sanofi has actually brought in a late entry to the radioligand celebration, paying for 100 thousand...
.After F2G's initial effort to acquire a brand-new class of antifungal to market was actually derail...
.Moderna has sworn to cut R&D spending by $1.1 billion through 2027. The selection to retract the...
.Just four months after Sanofi bet $80 million in ahead of time cash on Pivot Therapeutics' losmapim...
.Cancer cells provider Oncternal Rehabs is folding all its own medical trials and also laying off wo...
.Roche is holding out chances that its own injectable weight problems prospect might ultimately demo...
.Novo Nordisk has actually lifted the top on a stage 1 test of its own oral amylin and also GLP-1 re...
.Simply a couple of short weeks after winning an FDA Fast lane tag for its own investigational BTK d...